| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |